SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE, Nesland JM. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 1997; 79: 2282308.
  • 2
    Uehlinger P, Zellweger M, Wagnieres G, Juillerat-Jeanneret L, van den Bergh H, Lange N. 5-Aminolevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX formation in cultured cells. J Photochem Photobiol B 2000; 54: 7280.
  • 3
    Moan J, Ma LW, Iani V. On the pharmacokinetics of topically applied 5-aminolevulinic acid and two of its esters. Int J Cancer 2001; 92: 13943.
  • 4
    Williams AC, Barry BW. Skin absorption enhancers. Crit Rev Ther Drug Carrier Syst 1992; 9: 30553.
  • 5
    Shaw JE, Prevo M, Gale R, Yum SI. Percutaneous absorption. In: GoldsmithLA, ed. Physiology, biochemistry, and molecular biology of the skin. New York, Oxford: Oxford University Press, 1991. 14479.
  • 6
    Moan J, Sommer S. Uptake of the components of hematoporphyrin derivative by cells and tumors. Cancer Lett 1983; 21: 16774.
  • 7
    Moan J, Sommer S. Action spectra for hematoporphyrin derivative and Photofrin II with respect to sensitization of human cells in vitro to photoinactivation. Photochem Photobiol 1984; 40: 6314.
  • 8
    Moan J. The photochemical yield of singlet oxygen from porphyrins in different states of aggregation. Photochem Photobiol 1984; 39: 4459.
  • 9
    Ma L, Moan J, Peng Q, Iani V. Production of protoporphyrin IX induced by 5-aminolevulinic acid in transplanted human colon adenocarcinoma of nude mice can be increased by ultrasound. Int J Cancer 1998; 78: 4649.
  • 10
    Sorensen R, Juzenas P, Iani V, Moan J. Formation of protoporphyrin IX in mouse skin after topical application of 5-aminolevulinic acid and its methyl ester. In: EhrenbergB, BergK, Eds. Photochemotherapy of cancer and other diseases. EhrenbergB, BergK, eds. Proc SPIE 1999; 3563: 77–81.
  • 11
    Gerscher S, Connelly JP, Griffiths J, Brown SB, MacRobert AJ, Wong G, Rhodes LE. Comparison of the pharmacokinetics and phototoxicity of protoporphyrin IX metabolized from 5-aminolevulinic acid and two derivatives in human skin in vivo. Photochem Photobiol 2000; 72: 56974.
  • 12
    Moan J, Bissonnette R. Skin preparation. Patent Number WO 01/85125 A2. World Intellectual Property Organization 2001.
  • 13
    Stender IM, Bech-Thomsen N, Poulsen T, Wulf HC. Photodynamic therapy with topical δ-aminolevulinic acid delays UV photocarcinogenesis in hairless mice. Photochem Photobiol 1997; 66: 4936.
  • 14
    Sharfaei S, Juzenas P, Moan J, Bissonnette R. Weekly topical application of methyl aminolevulinate followed by light exposure delays the appearance of UV-induced skin tumors in mice. Arch Dermatol Res 2002; 294: 23742.
  • 15
    Juzenas P, Sorensen R, Iani V, Moan J. Clearance of protoporphyrin IX from mouse skin after topical application of 5-aminolevulinic acid and its methyl ester. In: EhrenbergB, BergK, Eds. Photochemotherapy of cancer and other diseases. EhrenbergB, BergK, eds. Proc SPIE 1999; 3563: 1616.
  • 16
    Moan J, Berg K, Gadmar OB, Iani V, Ma L, Juzenas P. The temperature dependence of protoporphyrin IX production in cells and tissues. Photochem Photobiol 1999; 70: 66973.